Additionally, the study by Vasileva et al. identified three regulators—SPRY4, ERRFI1, and RAB31—that are common feedback elements in EGFR and FGFR signaling across the gliomas analyzed, offering potential targets for developing therapeutic strategies to inhibit glioma infiltration and progression [168]. Here, ERRFI1 is linked to glioma.